SCHEMBL23950293

SCHEMBL23950293

CS(=O)(=O)CCn1cnc2c(-c3cccnc3)nc(-c3ccc(C(F)(F)F)cc3)cc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.42
PTGS1 P23219 1/20 0.42
GRM2 Q14416 1/20 0.38
PIM1 P11309 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
DDR1 Q08345 4/20 0.36
TOP1 P11387 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
CYP11B1 P15538 1/20 0.35
S1PR1 P21453 1/20 0.35
NPY5R Q15761 1/20 0.35
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
MET P08581 1/20 0.35
CYP2E1 P05181 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23925606 0.89 PSD (0.40) PTGS2PTGS1GRM2NPY5RADORA2A
SCHEMBL23950296 0.88 GRM2 (0.38) PTGS2PTGS1GRM2PIM1DDR1
SCHEMBL23950265 0.87 EGLN1 (0.39) PTGS2PTGS1GRM2PIM1TOP1
SCHEMBL23950531 0.85 PIM1 (0.41) PTGS2PTGS1PIM1TOP1SMN1; SMN2
SCHEMBL23390502 0.85 SMN1; SMN2 (0.38) PTGS2PTGS1GRM2PIM1TOP1
SCHEMBL23951142 0.83 SYK (0.47) PIM1
SCHEMBL30102064 0.83 PIM1 (0.37) PTGS2PTGS1GRM2PIM1TOP1
SCHEMBL23951123 0.83 PIM1 (0.37) PTGS2PTGS1GRM2PIM1TOP1
SCHEMBL23950768 0.82 EGLN1 (0.38) PTGS2PTGS1GRM2PIM1TOP1
SCHEMBL23950264 0.82 EGLN1 (0.38) PTGS2PTGS1GRM2PIM1TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115443276-B Pyridopyrimidinone derivatives and their use as arene receptor modulators 东亚ST株式会社 2025-04-18 CN claimed
CN-115443276-A Pyridopyrimidinone derivatives and their use as modulators of aromatic hydrocarbon receptors 东亚ST株式会社 2022-12-06 CN claimed
CN-115443276-B Pyridopyrimidinone derivatives and their use as arene receptor modulators 东亚ST株式会社 2025-04-18 CN disclosed
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 US disclosed
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 US disclosed
CN-115443276-A Pyridopyrimidinone derivatives and their use as modulators of aromatic hydrocarbon receptors 东亚ST株式会社 2022-12-06 CN disclosed
WO-2021210970-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, AIPL1 PTGS2 610/4885PTGS1 487/4885GRM2 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.